GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (FRA:ECQ0) » Definitions » Pretax Margin %

Neurizon Therapeutics (FRA:ECQ0) Pretax Margin % : % (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Neurizon Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Neurizon Therapeutics's Pre-Tax Income for the six months ended in Dec. 2024 was €-4.40 Mil. Neurizon Therapeutics's Revenue for the six months ended in Dec. 2024 was €0.00 Mil. Therefore, Neurizon Therapeutics's pretax margin for the quarter that ended in Dec. 2024 was %.

The historical rank and industry rank for Neurizon Therapeutics's Pretax Margin % or its related term are showing as below:

FRA:ECQ0' s Pretax Margin % Range Over the Past 10 Years
Min: -738.57   Med: -606.18   Max: -104.05
Current: -104.05


FRA:ECQ0's Pretax Margin % is ranked better than
52.06% of 995 companies
in the Biotechnology industry
Industry Median: -125.57 vs FRA:ECQ0: -104.05

Neurizon Therapeutics Pretax Margin % Historical Data

The historical data trend for Neurizon Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics Pretax Margin % Chart

Neurizon Therapeutics Annual Data
Trend Jun01 Jun02 Jun03 Jun04 Jun05 Jun24
Pretax Margin %
Get a 7-Day Free Trial -545.30 -667.80 -737.50 -104.07 -

Neurizon Therapeutics Semi-Annual Data
Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Jun24 Dec24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -73.03 -1.07 - - -

Competitive Comparison of Neurizon Therapeutics's Pretax Margin %

For the Biotechnology subindustry, Neurizon Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurizon Therapeutics's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurizon Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Neurizon Therapeutics's Pretax Margin % falls into.


;
;

Neurizon Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Neurizon Therapeutics's Pretax Margin for the fiscal year that ended in Jun. 2005 is calculated as

Pretax Margin=Pre-Tax Income (A: Jun. 2005 )/Revenue (A: Jun. 2005 )
=-2.123/2.04
=-104.07 %

Neurizon Therapeutics's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-4.403/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurizon Therapeutics  (FRA:ECQ0) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Neurizon Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Neurizon Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurizon Therapeutics Business Description

Traded in Other Exchanges
Address
96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines